Comparative effectiveness and medical cost of Dabigatran versus vitamin K antagonists from engel 2: a french nationwide cohort of 100 000 patients with non-valvular atrial fibrillation

P. Blin; G. de Pourvouville; Y. Cottin; C. Dureau-Pournin; A. Abouelfath; R. Lassalle; J. Bénichou; C. Droz-Perroteau; P. Mismetti; N. Moore

Comparative effectiveness and medical cost of Dabigatran versus vitamin K antagonists from engel 2: a french nationwide cohort of 100 000 patients with non-valvular atrial fibrillation

P. Blin ¹ G. de Pourvouville ² Y. Cottin ³ C. Dureau-Pournin ² A. Abouelfath ² R. Lassalle ² J. Bénichou ⁴ C. Droz-Perroteau ² P. Mismetti ⁵ N. Moore ¹

1 CIC Bordeaux

2 ESSEC Business School [Cergy-Pontoise]

3 CHU Dijon

4 BPH - Bordeaux population health

5 Hôpital Nord (Saint Etienne)

Type de document :

Poster

Domaine :

Sciences du Vivant [q-bio] / Sciences pharmaceutiques

Liste complète des métadonnées

https://hal-univ-bourgogne.archives-ouvertes.fr/hal-01680914
Contributeur : Lnc - Université de Bourgogne <>
Soumis le : jeudi 11 janvier 2018 - 11:07:50
Dernière modification le : mardi 5 mars 2019 - 10:54:03

Comparative effectiveness and medical cost of Dabigatran versus vitamin K antagonists from engel 2: a french nationwide cohort of 100 000 patients with non-valvular atrial fibrillation

Identifiants

Collections

Citation

Exporter

Métriques

43

Contact

Comparative effectiveness and medical cost of Dabigatran versus vitamin K antagonists from engel 2: a french nationwide cohort of 100 000 patients with non-valvular atrial fibrillation

Identifiants

Collections

Citation

Exporter

Partager

Métriques

43

Contact